These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 16461306

  • 1. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H, Johansson E, Björkholm M, Kalin M.
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [Abstract] [Full Text] [Related]

  • 2. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [Abstract] [Full Text] [Related]

  • 3. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cordonnier C.
    Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
    [No Abstract] [Full Text] [Related]

  • 4. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND, Gan GG, Adeeba K.
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [Abstract] [Full Text] [Related]

  • 5. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 6. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 7. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES.
    J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511
    [Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 20; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 9. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Bellesso M, Costa SF, Pracchia LF, Santos Dias LC, Chamone D, Dorlhiac-Llacer PE.
    Ann Hematol; 2011 Apr 20; 90(4):455-62. PubMed ID: 20852999
    [Abstract] [Full Text] [Related]

  • 10. Outpatient therapy for febrile neutropenia.
    Innes H, Marshall E.
    Curr Opin Oncol; 2007 Jul 20; 19(4):294-8. PubMed ID: 17545790
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM, Herrera L, Sandler ES, Buchanan GR.
    Cancer; 2000 Apr 01; 88(7):1710-4. PubMed ID: 10738231
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H, Lim SL, Hall A, Chan SY, Bhalla N, Marshall E.
    Support Care Cancer; 2008 May 01; 16(5):485-91. PubMed ID: 17899215
    [Abstract] [Full Text] [Related]

  • 15. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 16. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar 01; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM, Moneer MM, Ismail MM, Shalaby LM, El-Mahallawy HA.
    J Pediatr Hematol Oncol; 2007 Mar 01; 29(3):131-6. PubMed ID: 17356388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.